title: Antiretroviral nanoparticles: an extended drug delivery modality.
abstract: The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.
authors: Creighton University, School of Pharmacy & Health Professions, 2500 California Plaza, Omaha, NE 68178, USA. destache@creighton.edu
authors: Christopher J
authors: CJ
authors: Destache
authors: Michael
authors: M
authors: Goede
authors: Todd
authors: T
authors: Belgum
mesh_terms: D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D004337:Drug Carriers; D004338:Drug Combinations; D004339:Drug Compounding; D015658:HIV Infections / Q000188:drug therapy* / Q000378:metabolism / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D050997:Nanomedicine; D053758:Nanoparticles; D011108:Polymers / Q000737:chemistry*; D013678:Technology, Pharmaceutical / Q000379:methods*
chemical_list: D019380:Anti-HIV Agents; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004338:Drug Combinations; D011108:Polymers